You have not verified your Email yet. Please verify your Email to create alerts
Verify EmailTTKHLTCARE
TTK Healthcare
|
Thyrocare Tech.
|
Elin Electronics
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
22.38 % | n/a | n/a |
R&D as a % of Total Sales
|
0.18 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
22.02 % | 23.13 % | 10.29 % |
5yr average Equity Multiplier
|
1.58 | 1.36 | 1.81 |
5yr Average Asset Turnover Ratio
|
1.15 | 0.81 | 1.83 |
5yr Avg Net Profit Margin
|
22.14 % | 21.31 % | 3.07 % |
Price to Book
|
2.22 | 6.71 | 1.64 |
P/E
|
33.24 | 49.76 | 68.36 |
5yr Avg Cash Conversion Cycle
|
-41.8 Days | 34.58 Days | 53.06 Days |
Inventory Days
|
41.67 Days | 16.27 Days | 38.04 Days |
Days Receivable
|
36.67 Days | 61.79 Days | 63.6 Days |
Days Payable
|
102.9 Days | 42.25 Days | 49.81 Days |
5yr Average Interest Coverage Ratio
|
11.04 | 114.35 | 4.11 |
5yr Avg ROCE
|
9.07 % | 30.71 % | 15.06 % |
5yr Avg Operating Profit Margin
|
7.68 % | 37.85 % | 7.15 % |
5 yr average Debt to Equity
|
0.07 | 0.0 | 0.35 |
5yr CAGR Net Profit
|
92.23 % | -5.02 % | 8.7 % |
5yr Average Return on Assets
|
16.15 % | 17.28 % | 5.61 % |
Shareholdings
|
|||
Promoter Holding
|
74.56 % | 71.11 % | 33.41 % |
Share Pledged by Promoters
|
0.0 | 100.0 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 4.97 % | 0.48 % |
Change in Mutual Fund Holding (3 Yrs)
|
-2.29 % | 8.08 % | -0.37 % |
TTK Healthcare
|
Thyrocare Tech.
|
Elin Electronics
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|